Pyrido[2,3-d]pyrimidine-2,4-diamines as PDE 2 inhibitors

Details for Australian Patent Application No. 2004303609 (hide)

Owner Pfizer Products Inc.

Inventors Li, Mei; Thompson, David Duane; Beyer, Thomas Arthur; Lam, Kelvin; Chambers, Robert James; Morrell, Andrew Ian

Agent Shelston IP

Pub. Number AU-A-2004303609

PCT Pub. Number WO2005/061497

Priority 60/529,994 16.12.03 US

Filing date 6 December 2004

Wipo publication date 7 July 2005

International Classifications

A61K 31/00 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/061497 Priority application(s): WO2005/061497

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303612-Oligonucleotides for the detection of hepatitis B virus

2004303604-Heterocyclic derivatives as GPCR receptor agonists